Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Change in Receivables (2022 - 2026)

Indivior Pharmaceuticals has reported Change in Receivables over the past 5 years, most recently at $20.0 million for Q1 2026.

  • For Q1 2026, Change in Receivables rose 281.82% year-over-year to $20.0 million; the TTM value through Mar 2026 reached $28.0 million, up 566.67%, while the annual FY2025 figure was -$3.0 million, 400.0% down from the prior year.
  • Change in Receivables for Q1 2026 was $20.0 million at Indivior Pharmaceuticals, up from -$6.0 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $59.0 million in Q4 2023 and troughed at -$18.0 million in Q3 2023.
  • A 5-year average of $4.6 million and a median of -$1.0 million in 2022 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: crashed 1700.0% in 2023 and later skyrocketed 300.0% in 2025.
  • Year by year, Change in Receivables stood at $19.0 million in 2022, then skyrocketed by 210.53% to $59.0 million in 2023, then tumbled by 93.22% to $4.0 million in 2024, then crashed by 250.0% to -$6.0 million in 2025, then soared by 433.33% to $20.0 million in 2026.
  • Business Quant data shows Change in Receivables for INDV at $20.0 million in Q1 2026, -$6.0 million in Q4 2025, and $18.0 million in Q3 2025.